SARS-CoV-2 ORF7a 抗体 (AA 16-111)
-
- 抗原 See all SARS-CoV-2 ORF7a products
- SARS-CoV-2 ORF7a
-
抗原表位
- AA 16-111
- 适用
- SARS Coronavirus (SARS-CoV)
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This SARS-CoV-2 ORF7a antibody is un-conjugated
- 应用范围
- Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)
- 交叉反应
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
- 纯化方法
- Affinity purified by Protein G.
- 免疫原
- The immunogen used to generate this antibody corresponds to SARS-CoV ORF7a protein (16-111 a.a.).
- 克隆位点
- 3C9
- 亚型
- IgG1
-
-
- 应用备注
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- 说明
-
Positive Control: ORF7a-transfected 293T cell
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- PBS, No Preservative
- 储存液
- Without preservative
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- 抗原
- SARS-CoV-2 ORF7a
- Abstract
- SARS-CoV-2 ORF7a 产品
- 别名
- ORF7a protein antibody, ORF7a antibody
- 背景
- 2019-nCoV ORF7a , SARS-coV-2 ORF7a , COVID-19 ORF7a
-